The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
Related Posts
CNBC’s The China Connection newsletter: U.S.-China relations have changed
The world got a taste of an effective U.S.-China trade embargo, and there’s no going back.
Bank of Japan hikes policy rates by 25 basis points to highest since 2008
The move comes in line with expectations from CNBC’s survey from Jan 15-20, which saw an overwhelming majority of economists…
Transforming the physical world with AI: the next frontier in intelligent automation
The convergence of artificial intelligence with physical systems marks a pivotal moment in technological evolution. Physical AI, where algorithms transcend…